Concepts (179)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, Steroid | 4 | 2017 | 33 | 2.130 |
Why?
|
| Liver | 13 | 2021 | 447 | 1.580 |
Why?
|
| Hepatocytes | 4 | 2015 | 74 | 1.490 |
Why?
|
| Ethanol | 6 | 2017 | 188 | 1.480 |
Why?
|
| Retinoid X Receptor alpha | 5 | 2009 | 8 | 1.360 |
Why?
|
| Obesity | 4 | 2021 | 965 | 1.060 |
Why?
|
| Liver Diseases, Alcoholic | 3 | 2015 | 7 | 0.840 |
Why?
|
| Methionine | 3 | 2008 | 28 | 0.740 |
Why?
|
| Fatty Liver, Alcoholic | 2 | 2017 | 2 | 0.720 |
Why?
|
| Inflammation | 3 | 2021 | 577 | 0.710 |
Why?
|
| Plants, Medicinal | 6 | 2004 | 54 | 0.690 |
Why?
|
| Choline Deficiency | 2 | 2008 | 3 | 0.660 |
Why?
|
| Mice | 18 | 2023 | 5668 | 0.660 |
Why?
|
| Up-Regulation | 2 | 2017 | 490 | 0.600 |
Why?
|
| Fatty Liver | 3 | 2020 | 56 | 0.550 |
Why?
|
| Dietary Fats | 2 | 2014 | 115 | 0.540 |
Why?
|
| Animals | 23 | 2023 | 14307 | 0.540 |
Why?
|
| Mice, Knockout | 8 | 2023 | 897 | 0.540 |
Why?
|
| Tannins | 3 | 2004 | 4 | 0.520 |
Why?
|
| Hydrolyzable Tannins | 3 | 2004 | 14 | 0.520 |
Why?
|
| Balanophoraceae | 2 | 2004 | 2 | 0.510 |
Why?
|
| Antioxidants | 5 | 2004 | 386 | 0.470 |
Why?
|
| Mice, Inbred C57BL | 6 | 2021 | 1530 | 0.460 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 2 | 2010 | 58 | 0.460 |
Why?
|
| Glucose | 1 | 2013 | 217 | 0.430 |
Why?
|
| Plant Extracts | 4 | 2004 | 250 | 0.410 |
Why?
|
| Lipid Peroxidation | 3 | 2015 | 131 | 0.380 |
Why?
|
| Mixed Function Oxygenases | 3 | 2005 | 29 | 0.360 |
Why?
|
| Glutathione Transferase | 3 | 2005 | 83 | 0.360 |
Why?
|
| Cholestasis | 1 | 2009 | 9 | 0.350 |
Why?
|
| Male | 16 | 2021 | 18870 | 0.340 |
Why?
|
| RNA, Messenger | 6 | 2017 | 1152 | 0.340 |
Why?
|
| Pyrimidines | 1 | 2009 | 112 | 0.320 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 2 | 2005 | 49 | 0.320 |
Why?
|
| Cytokines | 2 | 2009 | 569 | 0.310 |
Why?
|
| Cytochrome P-450 CYP2E1 | 3 | 2015 | 14 | 0.300 |
Why?
|
| Lipids | 1 | 2007 | 222 | 0.280 |
Why?
|
| Diet | 2 | 2008 | 747 | 0.250 |
Why?
|
| Gene Expression Regulation | 4 | 2014 | 968 | 0.240 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2004 | 82 | 0.240 |
Why?
|
| Free Radical Scavengers | 3 | 2000 | 65 | 0.230 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2004 | 160 | 0.230 |
Why?
|
| Picrates | 2 | 2000 | 7 | 0.230 |
Why?
|
| Mice, Transgenic | 2 | 2015 | 608 | 0.220 |
Why?
|
| Enzyme Inhibitors | 1 | 2004 | 396 | 0.220 |
Why?
|
| Hepatomegaly | 2 | 2013 | 5 | 0.210 |
Why?
|
| Alcohol Dehydrogenase | 2 | 2015 | 8 | 0.210 |
Why?
|
| Atherosclerosis | 1 | 2023 | 131 | 0.210 |
Why?
|
| Liver Function Tests | 3 | 2008 | 18 | 0.210 |
Why?
|
| RNA, Bacterial | 1 | 2021 | 29 | 0.200 |
Why?
|
| Glucose Tolerance Test | 1 | 2021 | 66 | 0.200 |
Why?
|
| Autophagy | 2 | 2020 | 111 | 0.200 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2021 | 165 | 0.190 |
Why?
|
| Gene Regulatory Networks | 1 | 2021 | 115 | 0.190 |
Why?
|
| Endothelial Cells | 1 | 2023 | 296 | 0.180 |
Why?
|
| Female | 6 | 2021 | 19873 | 0.170 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2020 | 146 | 0.170 |
Why?
|
| Bile Acids and Salts | 2 | 2009 | 31 | 0.170 |
Why?
|
| Aflatoxin B1 | 1 | 1998 | 4 | 0.170 |
Why?
|
| Receptors, Notch | 1 | 2018 | 32 | 0.170 |
Why?
|
| Serotonin | 1 | 2018 | 114 | 0.160 |
Why?
|
| Sex Factors | 1 | 2021 | 859 | 0.160 |
Why?
|
| Lipogenesis | 1 | 2017 | 18 | 0.160 |
Why?
|
| Rats, Sprague-Dawley | 4 | 2004 | 1534 | 0.160 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2020 | 147 | 0.160 |
Why?
|
| Rats | 5 | 2004 | 3261 | 0.160 |
Why?
|
| Microsomes, Liver | 3 | 2004 | 69 | 0.160 |
Why?
|
| Liver Neoplasms | 1 | 2020 | 195 | 0.150 |
Why?
|
| Gene Deletion | 1 | 2017 | 156 | 0.150 |
Why?
|
| Aldehyde Dehydrogenase | 1 | 2015 | 14 | 0.140 |
Why?
|
| Humans | 9 | 2020 | 34853 | 0.140 |
Why?
|
| Cyclin D1 | 1 | 2015 | 42 | 0.130 |
Why?
|
| Thiobarbituric Acid Reactive Substances | 2 | 2008 | 15 | 0.130 |
Why?
|
| Estrogen Receptor alpha | 1 | 2015 | 105 | 0.130 |
Why?
|
| Isoenzymes | 2 | 2006 | 149 | 0.130 |
Why?
|
| Cytochrome P-450 CYP3A | 1 | 2014 | 22 | 0.120 |
Why?
|
| Adipose Tissue, White | 1 | 2014 | 13 | 0.120 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2007 | 605 | 0.120 |
Why?
|
| Glucokinase | 1 | 2013 | 3 | 0.120 |
Why?
|
| Carnitine O-Palmitoyltransferase | 1 | 2013 | 5 | 0.120 |
Why?
|
| Hyperinsulinism | 1 | 2013 | 17 | 0.120 |
Why?
|
| Glucose Intolerance | 1 | 2014 | 42 | 0.120 |
Why?
|
| Ion Channels | 1 | 2014 | 69 | 0.120 |
Why?
|
| Medicine, African Traditional | 2 | 2004 | 3 | 0.120 |
Why?
|
| Sex Characteristics | 1 | 2015 | 213 | 0.120 |
Why?
|
| Cell Proliferation | 3 | 2020 | 1149 | 0.120 |
Why?
|
| PPAR alpha | 1 | 2013 | 42 | 0.120 |
Why?
|
| Species Specificity | 1 | 2013 | 233 | 0.120 |
Why?
|
| Mitochondrial Proteins | 1 | 2014 | 96 | 0.120 |
Why?
|
| Ghana | 2 | 2005 | 27 | 0.110 |
Why?
|
| Oxidative Stress | 2 | 2008 | 874 | 0.110 |
Why?
|
| Free Radicals | 3 | 2002 | 72 | 0.110 |
Why?
|
| Adipose Tissue | 1 | 2013 | 167 | 0.110 |
Why?
|
| Blood Glucose | 1 | 2014 | 333 | 0.110 |
Why?
|
| Injections, Intraperitoneal | 2 | 2004 | 58 | 0.100 |
Why?
|
| Lipid Metabolism | 2 | 2008 | 109 | 0.100 |
Why?
|
| Alcohol Drinking | 1 | 2015 | 490 | 0.100 |
Why?
|
| Organ Size | 2 | 2008 | 148 | 0.100 |
Why?
|
| Endocrine System | 1 | 2010 | 12 | 0.100 |
Why?
|
| Membrane Proteins | 1 | 2014 | 486 | 0.090 |
Why?
|
| Signal Transduction | 1 | 2018 | 1802 | 0.090 |
Why?
|
| Homeostasis | 2 | 2008 | 172 | 0.090 |
Why?
|
| Cholesterol 7-alpha-Hydroxylase | 1 | 2009 | 2 | 0.090 |
Why?
|
| Steroid 12-alpha-Hydroxylase | 1 | 2009 | 2 | 0.090 |
Why?
|
| Peroxisomes | 1 | 2009 | 4 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2023 | 245 | 0.090 |
Why?
|
| Aspartate Aminotransferases | 2 | 1999 | 15 | 0.090 |
Why?
|
| Alanine Transaminase | 2 | 1999 | 26 | 0.090 |
Why?
|
| Organic Anion Transporters, Sodium-Independent | 1 | 2008 | 1 | 0.090 |
Why?
|
| Body Weight | 2 | 2008 | 404 | 0.080 |
Why?
|
| Coloring Agents | 1 | 2008 | 51 | 0.080 |
Why?
|
| Glutathione | 2 | 2008 | 160 | 0.080 |
Why?
|
| Multidrug Resistance-Associated Proteins | 1 | 2008 | 42 | 0.080 |
Why?
|
| Food, Formulated | 1 | 2008 | 4 | 0.080 |
Why?
|
| Hepatitis | 1 | 2008 | 10 | 0.080 |
Why?
|
| Liver Cirrhosis | 1 | 2008 | 51 | 0.080 |
Why?
|
| S-Adenosylmethionine | 1 | 2008 | 33 | 0.080 |
Why?
|
| Disease Models, Animal | 2 | 2010 | 1300 | 0.080 |
Why?
|
| Mice, Inbred DBA | 1 | 2007 | 69 | 0.080 |
Why?
|
| Mice, Inbred Strains | 1 | 2007 | 117 | 0.080 |
Why?
|
| Fatty Acids | 1 | 2008 | 118 | 0.080 |
Why?
|
| Choline | 1 | 2008 | 57 | 0.080 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2008 | 73 | 0.070 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2013 | 592 | 0.070 |
Why?
|
| Blotting, Western | 1 | 2008 | 834 | 0.070 |
Why?
|
| Genotype | 2 | 2005 | 641 | 0.070 |
Why?
|
| Acetaminophen | 1 | 2005 | 24 | 0.070 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 2005 | 29 | 0.070 |
Why?
|
| Gene Frequency | 1 | 2005 | 155 | 0.060 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2004 | 81 | 0.060 |
Why?
|
| Gene Expression | 1 | 2007 | 639 | 0.060 |
Why?
|
| Cytosol | 1 | 2004 | 85 | 0.060 |
Why?
|
| Lymphangiogenesis | 1 | 2023 | 1 | 0.060 |
Why?
|
| Polymorphism, Genetic | 1 | 2004 | 165 | 0.060 |
Why?
|
| Polymerase Chain Reaction | 1 | 2005 | 430 | 0.060 |
Why?
|
| Thrombospondin 1 | 1 | 2023 | 22 | 0.060 |
Why?
|
| Bepridil | 2 | 2000 | 2 | 0.060 |
Why?
|
| Carbon Tetrachloride | 2 | 2000 | 5 | 0.060 |
Why?
|
| Biphenyl Compounds | 2 | 2000 | 52 | 0.060 |
Why?
|
| Edetic Acid | 1 | 2002 | 21 | 0.050 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2023 | 157 | 0.050 |
Why?
|
| Chelating Agents | 1 | 2002 | 53 | 0.050 |
Why?
|
| Molecular Conformation | 1 | 2002 | 150 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2004 | 984 | 0.050 |
Why?
|
| Artemisia | 1 | 2000 | 4 | 0.050 |
Why?
|
| Lung Neoplasms | 1 | 2004 | 336 | 0.050 |
Why?
|
| Reactive Oxygen Species | 1 | 2002 | 416 | 0.050 |
Why?
|
| Aniline Hydroxylase | 1 | 1999 | 2 | 0.040 |
Why?
|
| Galactosamine | 1 | 1999 | 3 | 0.040 |
Why?
|
| Time Factors | 1 | 2004 | 1681 | 0.040 |
Why?
|
| Liver Diseases | 1 | 1999 | 31 | 0.040 |
Why?
|
| Receptor, Serotonin, 5-HT1B | 1 | 2018 | 2 | 0.040 |
Why?
|
| Transfection | 1 | 2020 | 496 | 0.040 |
Why?
|
| Hep G2 Cells | 1 | 2018 | 52 | 0.040 |
Why?
|
| Rats, Inbred F344 | 1 | 1998 | 228 | 0.040 |
Why?
|
| Smoking | 1 | 2004 | 903 | 0.040 |
Why?
|
| Cell Survival | 1 | 2018 | 818 | 0.030 |
Why?
|
| Middle Aged | 2 | 2005 | 9642 | 0.030 |
Why?
|
| Aged | 1 | 2005 | 6448 | 0.030 |
Why?
|
| Adult | 2 | 2005 | 11034 | 0.030 |
Why?
|
| Malondialdehyde | 1 | 2008 | 38 | 0.020 |
Why?
|
| Mice, Obese | 1 | 2008 | 37 | 0.020 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2008 | 39 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2008 | 78 | 0.020 |
Why?
|
| Triglycerides | 1 | 2008 | 129 | 0.020 |
Why?
|
| Cholesterol | 1 | 2008 | 194 | 0.020 |
Why?
|
| Metabolic Detoxication, Phase II | 1 | 2005 | 4 | 0.020 |
Why?
|
| Disease Progression | 1 | 2008 | 580 | 0.020 |
Why?
|
| Carcinoma, Small Cell | 1 | 2004 | 6 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2005 | 406 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2004 | 517 | 0.010 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2004 | 176 | 0.010 |
Why?
|
| Adenocarcinoma | 1 | 2004 | 239 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2004 | 1056 | 0.010 |
Why?
|
| Spectrophotometry, Infrared | 1 | 2000 | 35 | 0.010 |
Why?
|
| Africa | 1 | 2000 | 62 | 0.010 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 2000 | 94 | 0.010 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2000 | 281 | 0.010 |
Why?
|
| Risk Factors | 1 | 2004 | 3414 | 0.010 |
Why?
|